CLVS

Clovis Oncology, Inc.

Delisted

CLVS was delisted on the 20th of December, 2022.

151 hedge funds and large institutions have $198M invested in Clovis Oncology, Inc. in 2021 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 54 increasing their positions, 38 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
151
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$4.29M
Puts
$5.93M
Net Calls
Net Calls Change

Top Buyers

1 +$3.92M
2 +$3.9M
3 +$3.04M
4
Rafferty Asset Management
Rafferty Asset Management
New York
+$1.68M
5
Citigroup
Citigroup
New York
+$1.51M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$43.7M
2
$27.4M
3
$26.4M
4
$21.3M
5
$10.8M
6
$6M
7
$4.13M
8
$3.67M
9
$3.61M
10
$3.16M
11
$3.02M
12
$2.97M
13
$2.92M
14
$2.77M
15
$2.31M
16
$1.91M
17
$1.65M
18
$1.51M
19
$1.37M
20
$1.35M
21
$1.34M
22
$1.19M
23
$1.18M
24
$1.09M
25
$999K